Femimens and Femicycle - new products in the gynecological portfolio.5 Feb 2019
Femimens and Femicycle are the new products in Ananta Medicare Ltd's gynecological portfolio.
Femimens is a phytocomplex product, developed specifically for the correction of dishormonal balance of women. Due to its unique composition, Femimens provides a polymodal pharmacological effect on the main pathogenetic links of premenstrual syndrome, hyperprolactinemia and age-related dishormonal disorders.
Femimens composition contains Vitex agnus castus extractum (125 mg), which has antihyperprolactin, dopamine and estrogen-modulating, analgesic, anti-inflammatory, antimicrobial and antitumor effects.
Vitex agnus castus extractum slows down dysplastic processes in the glands and stromal tissue of the mammary gland, prevents the pathological development of connective tissue, normalizes the size of lacrimal sinuses and ducts, and reduces the discomfort when breast engorgement.
Withania somnifera extractum (100 mg) has soothing, anti-stress, anti-inflammatory, antitumor, antioxidant, spasmolytic, analgesic and immunomodulatory effects.
Zingiber officinale extractum (35 mg) exhibits analgesic, anti-inflammatory and antibacterial effects.
Trigonella foenum-graecum extractum (30 mg) has anti-inflammatory, analgesic, antioxidant effects and normalizes blood progesterone concentrations.
The optimally selected composition of Feimimens is recommended for reducing the intensity and elimination of PMS symptoms, and for manifestations of premenstrual dysphoric disorders. Also it is recommened in involutional changes of the mammary glands and age-related dyshormonal conditions. It can be used as an additional component to the complex correction of hyperprolactinemic states, including menstrual disorders, caused by hyperprolactinemia.
Today, menstrual disorders are a frequent pathological condition of the reproductive system. Femicycle has been developed as an effective alternative therapy for menstrual disorders.
Femicycle composition contains 5 ingredients:
Symplocos racemosa extractum – 125 mg;
Asparagus racemosus extractum – 100 mg;
Saraca indica extractum – 100 mg;
Glycyrrhiza glabra extractum – 50 mg;
Curcuma longa extractum – 40 mg.
The optimally selected multicomponent composition of Femicycle provides a complex pharmacological action in menstrual disorders.
Symplocos racemosa extractum normalizes the levels of follicle-stimulating (FSH) and luteinizing (LH) hormones in blood serum. Also it protects the hormones of women under stress. It has anti-inflammatory, antispasmodic and antitumor effects as well as exhibits an antioxidant activity.
Asparagus racemosus extractum has phytoestrogenic properties. It has antitumor, immunomodulatory, anti-inflammatory, spasmolytic, antioxidant and antibacterial effects.
Glycyrrhiza glabra extractum has anti-inflammatory, spasmolytic, soothing and pronounced antitumor effects.
Saraca indica extractum has spasmolytic, antibacterial and antitumor effects, and exhibits an estrogenic activity.
Curcuma longa extractum has antioxidant, anti-inflammatory, antimicrobial and antitumor effects.
The unique composition, good tolerability and safety of Femicycle phytocomplex allow to recommend it for the treatment and prevention of various menstrual disorders.
Are you a supplier?
Here's what CPhI Online can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation